D.E. Shaw & Co’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-19,056
| Closed | -$241K | – | 4161 |
|
|
2022
Q2 | $241K | Buy |
19,056
+892
| +5% | +$11.3K | ﹤0.01% | 3320 |
|
|
2022
Q1 | $1.05M | Buy |
18,164
+9,064
| +100% | +$521K | ﹤0.01% | 2855 |
|
|
2021
Q4 | $1.08M | Buy |
9,100
+7,960
| +698% | +$946K | ﹤0.01% | 2693 |
|
|
2021
Q3 | $227K | Sell |
1,140
-699
| -38% | -$139K | ﹤0.01% | 3195 |
|
|
2021
Q2 | $320K | Sell |
1,839
-671
| -27% | -$117K | ﹤0.01% | 3070 |
|
|
2021
Q1 | $497K | Sell |
2,510
-1,959
| -44% | -$388K | ﹤0.01% | 2497 |
|
|
2020
Q4 | $879K | Buy |
4,469
+699
| +19% | +$137K | ﹤0.01% | 2081 |
|
|
2020
Q3 | $669K | Buy |
3,770
+52
| +1% | +$9.23K | ﹤0.01% | 2023 |
|
|
2020
Q2 | $860K | Buy |
3,718
+2,628
| +241% | +$608K | ﹤0.01% | 1965 |
|
|
2020
Q1 | $127K | Buy |
+1,090
| New | +$127K | ﹤0.01% | 2530 |
|
|
2019
Q3 | – | Sell |
-2,015
| Closed | -$345K | – | 2747 |
|
|
2019
Q2 | $345K | Buy |
2,015
+1,259
| +167% | +$216K | ﹤0.01% | 2260 |
|
|
2019
Q1 | $152K | Buy |
+756
| New | +$152K | ﹤0.01% | 2410 |
|